PBMares Wealth Management LLC Has $420,000 Position in UnitedHealth Group Incorporated (NYSE:UNH)

PBMares Wealth Management LLC trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 57.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 801 shares of the healthcare conglomerate's stock after selling 1,074 shares during the quarter. PBMares Wealth Management LLC's holdings in UnitedHealth Group were worth $420,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently added to or reduced their stakes in UNH. Geode Capital Management LLC lifted its position in shares of UnitedHealth Group by 1.6% in the fourth quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate's stock worth $10,068,869,000 after buying an additional 319,515 shares during the last quarter. Capital International Investors raised its stake in UnitedHealth Group by 6.2% during the 4th quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock valued at $7,899,905,000 after purchasing an additional 906,365 shares during the last quarter. Norges Bank acquired a new position in UnitedHealth Group in the 4th quarter valued at approximately $6,375,744,000. Northern Trust Corp raised its stake in shares of UnitedHealth Group by 12.5% in the fourth quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock valued at $4,807,527,000 after purchasing an additional 1,058,488 shares in the last quarter. Finally, Franklin Resources Inc. raised its position in UnitedHealth Group by 10.7% in the fourth quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate's stock worth $4,514,178,000 after purchasing an additional 861,854 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other UnitedHealth Group news, Director Kristen Gil bought 3,700 shares of the firm's stock in a transaction that occurred on Thursday, May 15th. The shares were acquired at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the acquisition, the director now owns 3,818 shares of the company's stock, valued at $1,035,327.06. The trade was a 3,135.59% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director John H. Noseworthy acquired 300 shares of the firm's stock in a transaction on Wednesday, May 14th. The stock was bought at an average price of $312.16 per share, for a total transaction of $93,648.00. Following the completion of the acquisition, the director now owns 6,063 shares of the company's stock, valued at approximately $1,892,626.08. The trade was a 5.21% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have bought 109,408 shares of company stock worth $31,607,768. Insiders own 0.28% of the company's stock.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the company. HSBC reissued a "reduce" rating and issued a $270.00 target price (down from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Bank of America cut UnitedHealth Group from a "buy" rating to a "neutral" rating and dropped their price target for the company from $560.00 to $350.00 in a report on Wednesday, May 14th. Wells Fargo & Company restated an "overweight" rating on shares of UnitedHealth Group in a research note on Friday, June 6th. Argus lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Monday, April 21st. Finally, Deutsche Bank Aktiengesellschaft lowered their price target on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a report on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and a consensus target price of $427.09.

UnitedHealth Group Stock Performance

UNH opened at $300.85 on Tuesday. The business's 50-day moving average price is $353.44 and its two-hundred day moving average price is $460.22. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The company has a market capitalization of $272.91 billion, a price-to-earnings ratio of 12.60, a P/E/G ratio of 1.42 and a beta of 0.45. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same quarter last year, the business earned $6.91 earnings per share. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be given a dividend of $2.21 per share. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date is Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 2.94%. UnitedHealth Group's payout ratio is 37.02%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.